Private Equity
Intudo Ventures has a laser focus on bringing investment and talent back to Southeast Asia
10 min read · 30 October 2019
Watertown, Massachusetts-based Arranta Bio, a biotech firm, has secured $82 million in funding. The investors included Ampersand Capital Partners and Thermo Fisher.
1 min read · 30 October 2019
1 min read · 29 October 2019
Centogene, a company focused on rare diseases, is seeking to raise about $60 million for its IPO after pricing its 4 million shares at a price range between $14 and $16 per share. Centogene is planning on trading the stock on the NASDAQ under the ticker symbol "CNTG." SVB Leerink and Evercore ISI are the lead underwriters. Centogene's backers include TVM Capital Life Science.
3 min read · 29 October 2019
Washington, D.C.-based Socially Determined, a healthcare technology startup, has raised over $7.3 million in Series A funding. The investors include Ziegler Link-Age Funds, ProMedica, 3M, OSF HealthCare and LRVHealth.
1 min read · 29 October 2019
Walnut, California-based BURST Oral Care, a subscription oral care company, has secured $20 million in funding. The investors include Volition Capital.
1 min read · 29 October 2019
St. Louis-based PierianDx, a clinical genomics informatics company, has raised $27 million in Series B funding. ATW Partners and SJF Ventures led the round with participation from other investors that included Health Catalyst Capital, Inova Health Systems, RTI International and ARUP Laboratories.
1 min read · 29 October 2019
New York and San Francisco-based Nuvation Bio Inc, an oncology startup, has secured $275 million in Series A financing. Omega Funds led the round.
1 min read · 29 October 2019
Boston-based Activ Surgical, digital intelligence company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility, has raised $11 million in funding. DNS Capital led the round.
1 min read · 29 October 2019
Sharecare, a digital health company that helps people manage all their health in one place, has raised an undisclosed amount of funding. The backer was Aflac Corporate Ventures, the corporate ventures arm of Aflac Incorporated. Goldman Sachs was financial adviser to Sharecare on the deal.
1 min read · 29 October 2019